Implication of atherosclerotic pathways and metabolic risk factors in the structural deterioration of bioprosthetic heart valves-II

动脉粥样硬化途径和代谢危险因素对生物人工心脏瓣膜结构恶化的影响-II

• 批准号: 279041
• 负责人: Mathieu Patrick
• 金额: $ 60.76万
• 依托单位: Institut universitaire de cardiologie et de pneumologie de Qubec - U Laval
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2013
• 资助国家: 加拿大
• 起止时间: 2013-03-01 至 2018-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=279041&lang=en
• 关键词: Inflammation; Lipid; Structural Deterioration; Valve Bioprostheses

Bioprosthesis (BP) are animal's derived tissues used by surgeons to replace diseased heart valves. These substitutes have many advantages for patients, including among them, the fact that these valves obviate the need for anti-coagulation treatment. Howev

生物瓣膜是外科医生用来替换病变心脏瓣膜的动物源性组织。这些替代品对患者有许多优点，其中包括这些瓣膜不需要抗凝治疗的事实。豪夫